Skip to main contentSkip to navigation
Sirius Investors
Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG

SPHDF
OTCHealthcare

SPHDF Financial Statements & Analysis

Complete financial statements for SPHDF including income statement, balance sheet, and cash flow statement. Analyze SPHDF's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.

TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).

Financial Health Score

Financial Health Score

/100
Unlock score for free

Already registered? Sign in

Income Statement

Revenue
-28.4%
Net Income
-3293.4%
Gross Margin
-52.9%
Operating Margin
-4891.5%

Balance Sheet

Current Ratio
26.8%
Debt to Equity
48.6%
Asset Turnover
-36.8%

Cash Flow

Operating Cash Flow
-1180.8%
Net Cash Flow
-147.3%
Free Cash Flow
-1239.7%
Cash Flow to Debt
-555.5%

Income Statement Comparison

Revenue & Net Income

Period Comparison

MetricTTM Q2 '25TTM Q4 '25ChangeImpact
Revenue162.57M116.33M28.4%
Gross Profit112.93M38.07M66.3%
Operating Income2.08M-71.14M3528.6%
Net Income-2.69M-91.21M3293.4%
EPS-0.06-1.873138.4%
EBITDA43.78M-48.49M210.8%
Gross Margin69.47%32.72%52.9%
Operating Margin1.28%-61.16%4891.5%
Net Income Margin-1.65%-78.41%4642.3%
R&D Expenses47.09M48.69M3.4%

Income Statement Full Table

Free users can view the last 3 periods. Upgrade to see the full history.

Upgrade
MetricTTM Q4 '25TTM Q2 '25TTM Q4 '24TTM Q2 '24TTM Q4 '23
Revenue116.33M162.57M142.49M
Gross Profit38.07M112.93M122.75M
Operating Income-71.14M2.08M17.17M
Net Income-91.21M-2.69M12.81M
EPS-1.87-0.060.28
EBITDA-48.49M43.78M62.81M
Gross Margin32.72%69.47%86.14%
Operating Margin-61.16%1.28%12.05%
Net Income Margin-78.41%-1.65%8.99%
R&D Expenses48.69M47.09M45.14M

Our detailed financial analysis helps investors understand SPHDF's business performance, operational efficiency, and financial health through comprehensive financial statement data presented in both quarterly and annual formats.

Track SPHDF's financial performance metrics including revenue, gross profit, operating income, net income, total assets, liabilities, shareholders' equity, operating cash flow, and free cash flow with historical comparison and trend analysis.

Financial Metrics

Want to dive deeper into SPHDF's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.

View Financial Metrics
Santhera Pharmaceuticals Holding AG (SPHDF) Financial Statements (2026): Income, Balance Sheet & Cash Flow | Sirius Investors